Given that genes highly correlated with clinical ICB resistance33 were over-expressed among postsurgical tumor tissues (Supplementary Fig. 25), we wondered whether IPI549@HMP-augmented RT could further enhance sensitivity to PD-L1 blockade. The gene discussed is CD274; the disease is neoplasm.